Stockreport

Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study [Yahoo! Finance]

Nanobiotix S.A. - ADSs  (NBTX) 
PDF stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced achievement of operational re [Read more]